Multifocal motor neuropathy with conduction block following treatment with infliximab.
Barber
Claire E
CE
Lee
Peter
P
Steinhart
A Hillary
AH
Lazarou
Jason
J
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001379:Azathioprine / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D004576:Electromyography; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D008297:Male; D016472:Motor Neuron Disease / Q000188:drug therapy / Q000209:etiology*; D018482:Muscle, Skeletal / Q000187:drug effects / Q000503:physiopathology; D009431:Neural Conduction / Q000187:drug effects* / Q000502:physiology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D000069285:Infliximab; D001379:Azathioprine